Co-Diagnostics Announces CFO Transition, Appoints Daniel Bohrer as Successor

Co-Diagnostics, Inc. announced the departure of Chief Financial Officer Brian Brown and the immediate appointment of Daniel Bohrer as the company's new principal financial and accounting officer, effective September 2, 2026.

Key Details

• Leadership Change: Brian Brown's employment as Chief Financial Officer ended on September 2, 2026.
• New Appointment: Daniel Bohrer, the company's Executive Vice President of Finance and Accounting, was promoted to principal financial and accounting officer on the same day.
• Compensation Update: In connection with his appointment, Mr. Bohrer’s annual salary was increased from $225,000 to $255,000.
• Background: Mr. Bohrer, age 49, joined Co-Diagnostics in September 2021 and previously served as Director of Accounting for Workfront, Inc. and as an Assurance Senior Manager at EY.